Image credits: naipo.de on Unsplash
/
Weekly Roundups

The End of the Pandemic?

By Miriam Bello | Wed, 01/26/2022 - 14:43

Mexico’s Deputy Minister of Health Hugo López-Gatell reported a slowdown in infections by COVID-19 this week. "This should be taken with caution but if it continues, it could (suggest) the beginning of a change in the (virus’) growth trend," he said. Meanwhile, the Institute for Health Metrics and Evaluation at the University of Washington estimated that 55 percent of Mexicans will have been infected with the Omicron variant by mid-February.

Here is the Week in Health!

COVID-19 Shifts Mortality Rates

COVID-19 was Mexico’s main cause of death during the first half of 2021, with 145,159 deaths. In second place were heart diseases with 113,899 deaths, followed by diabetes mellitus with 74,418, reported INEGI.

The End of the Pandemic?

The EU could be approaching the end of the COVID-19 pandemic, after 60 percent of its population contracted the Omicron variant before March, said Hans Kluge, Regional Director, WHO. Kluge acknowledged that “prudence” must be exercised due to the versatility of SARS-CoV-2.

Long-Term COVID-19 Explained

A group of scientists in Zurich, Switzerland, detected antibodies in the blood that could identify patients at higher risk of long-term COVID-19, which could help treat people who have symptoms that last up to months.

 Infections on Children Spike

During Jan. 1-16, there were 3,609 positive cases of COVID-19 in children, a sharp increase over the 668 cases reported during the first two weeks of December. This represents an increase of over 500 percent, according to data from the National System for the Comprehensive Protection of Children and Adolescents (SIPINNA), reported Animal Politico.

Antimicrobial Resistance on the Rise

About 1.2 million people die each year from infections caused by antibiotic-resistant bacteria. This is more than from diseases such as AIDS, malaria and some respiratory tract tumors, according to research from the University of Washington. Scientists believe that in less than 30 years these bacteria will cause 10 million deaths each year.

LSD to Treat Mental Illnesses

Canada's health authorities modified their regulations so doctors can use psychedelic drugs such as psilocybin, MDMA and LSD, among others, to treat mental illnesses such as depression and anxiety. Various scientific studies have supported their therapeutic benefits in patients.

Experts of the Week!

Do not miss our exclusive interviews with:

And be sure to check the expert contributions from:

Photo by:   naipo.de on Unsplash
Miriam Bello Miriam Bello Senior Journalist and Industry Analyst